| Literature DB >> 22340285 |
Ryan Doan1, Noah D Cohen, Jason Sawyer, Noushin Ghaffari, Charlie D Johnson, Scott V Dindot.
Abstract
BACKGROUND: The catalog of genetic variants in the horse genome originates from a few select animals, the majority originating from the Thoroughbred mare used for the equine genome sequencing project. The purpose of this study was to identify genetic variants, including single nucleotide polymorphisms (SNPs), insertion/deletion polymorphisms (INDELs), and copy number variants (CNVs) in the genome of an individual Quarter Horse mare sequenced by next-generation sequencing.Entities:
Mesh:
Year: 2012 PMID: 22340285 PMCID: PMC3309927 DOI: 10.1186/1471-2164-13-78
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Overview of genome-wide variation analysis pipeline by next generation sequencing.
Sequence generation and mapping to equCab2 reference genome
| Method | Lanes | Reads | Bases Mapped (Gb) | Average Depth of Coverage | % of Reference Mapped | Bases Mapped to ChrUn (Mb) | |
|---|---|---|---|---|---|---|---|
| 75 PE | 14 | 817,470,439 | 59.6 | 24.7 X | 97% | 935.1 | 19.1 |
Annotation of SNPs in the Quarter Horse genome
| Total | Homozygous | Heterozygous | Novel | Ensembl Genes | |
|---|---|---|---|---|---|
| 3,157,093 | 1,293,374 | 1,863,719 | 2,814,367 | 24,023 | |
| | 2,224,292 | 908,169 | 1,316,123 | 1,991,041 | 19,644 |
| | 40,948 | 19,241 | 21,707 | 37,566 | 12,803 |
| | 31,901 | 13,327 | 18,574 | 28,494 | 10,580 |
| | 929 | 427 | 502 | 866 | 399 |
| | 859,023 | 352,210 | 506,813 | 756,400 | 19,414 |
| | 811,204 | 332,455 | 478,749 | 712,764 | 14,778 |
| | 5,935 | 2,019 | 3,916 | 5,575 | 2,123 |
| | 1,734 | 1,014 | 720 | 1,630 | 1,049 |
| | 1,821 | 780 | 1,041 | 1,594 | 1,184 |
| | 300 | 185 | 115 | 280 | 276 |
| | 657 | 320 | 337 | 593 | 595 |
| | 37,372 | 15,437 | 21,935 | 33,964 | 10,485 (305 imprinted) |
| | 19,667 | 7,626 | 12,041 | 17,699 | 7,982 |
| | 214 | 50 | 164 | 206 | 190 |
| | 8 | 5 | 3 | 7 | 8 |
| | 18,140 | 8,076 | 10,064 | 16,645 | 6,899 |
Annotation of INDELs in the Quarter Horse genome
| INDEL Location | Total | Homozygous | Heterozygous |
|---|---|---|---|
| 193,271 | 127,173 | 66,098 | |
| 122,571 | 78,538 | 44,033 | |
| 5,900 | 5,073 | 827 | |
| 2,557 | 1,853 | 704 | |
| 126 | 105 | 21 | |
| 62,117 | 41,604 | 20,513 | |
| 57,618 | 37,377 | 20,241 | |
| 277 | 239 | 38 | |
| 594 | 557 | 37 | |
| 249 | 195 | 54 | |
| 749 | 735 | 14 | |
| 771 | 762 | 9 | |
| 1,859 | 1,739 | 120 | |
| 1,594 | 1,533 | 61 | |
| 980 | 940 | 40 | |
| 23 | 4 | 19 | |
| 12 | 5 | 7 | |
| 21 | 19 | 2 | |
Figure 2Biological process enrichment analysis of identified genetic variants. (A) BP enrichment analysis of non-synonymous coding SNPs, (B) INDELs, and (C) CNVs.
Analysis of genetic variants for known traits and diseases
| PMID | Chromosome | Coordinate | Gene | Gene Name | Phenotype | Associated Genotype | QH Genotype |
|---|---|---|---|---|---|---|---|
| 20353955 [ | 1 | 108,249,293 | transient receptor potential cation channel | Leopard complex spotting and congenital stationary night blindness | C/C C/T | T/T | |
| 17498917 [ | 1 | 128,056,148 | peptidyl-prolyl cis-trans isomerase B | Hereditary equine regional dermal asthenia | A/A | G/ | |
| 20419149 [ | 1 | 138,235,715 | myosin-Va isoform 1 | Lavender foal syndrome | Del 1 bp | Neg | |
| 8995760 [ | 3 | 36,259,552 | melanocyte-stimulating hormone receptor | Chestnut coat color | T/T | C/ | |
| 11086549 [ | 3 | 36,259,554 | melanocyte-stimulating hormone receptor | Chestnut coat color | A/A | G/G | |
| 16284805 [ | 3 | 77,735,520 | mast/stem cell growth factor receptor | Sabino spotting | A/A A/T | T/T | |
| 18253033 [ | 3 | 77,740,163 | mast/stem cell growth factor receptor | Tobiano spotting pattern | A/A A/G | G/G | |
| 21070277 [ | 4 | 38,969,307 | pyruvate dehydrogenase kinase isozyme 4 | Racing performance | A/A A/C | C/C | |
| 21070277 [ | 4 | 38,973,231 | pyruvate dehydrogenase kinase isozyme 4 | Racing performance | A/A A/G | G/G | |
| 12230513 [ | 5 | 20,256,789 | laminin subunit gamma-2 precursor | Junctional epidermolysis bullosa | Ins C | Neg | |
| 17029645 [ | 6 | 73,665,304 | melanocyte protein 17 precursor | Silver coat color | T/T T/C | C/C | |
| 19016681 [ | 8 | 45,603,643-45,610,231 | laminin alpha-3 | Junctional epidermolysis bullosa | Del 6,589 | Neg | |
| 9103416 [ | 9 | 35,528,429 | DNA-dependent protein kinase catalytic subunit | Severe combined immunodeficiency | Del 5 bp | Neg | |
| 15318347 [ | 10 | 9,554,699 | ryanodine receptor 1 isoform 2 | Malignant hyperthermia | G/G G/C | C/C | |
| 21059062 [ | 10 | 15,884,567 | creatine kinase M-type | Racing performance | A/A A/G | G/G | |
| 18358695 [ | 10 | 18,940,324 | glycogen [starch] synthase muscle | Polysaccharide storage myopathy | A/A A/G | G/G | |
| 7623088 [ | 11 | 15,500,439 | sodium channel protein type 4 subunit alpha | Equine hyperkalemic periodic paralysis | G/G G/C | C/C | |
| 18802473 [ | 14 | 26,701,092 | proton-coupled amino acid transporter 1 | Champagne dilution | C/C C/G | G/G | |
| 9580670 [ | 17 | 50,624,658 | endothelin B receptor precursor | Lethal white foal syndrome | AG/AG | TC/TC | |
| 20932346 [ | 18 | 66,493,737 | growth/differentiation factor 8 precursor | Optimum racing distance | T/T | ||
| 12605854 [ | 21 | 30,666,626 | membrane-associated transporter protein isoform | Cream coat color | A/A A/G | G/G | |
| 21059062 [ | 22 | 22,684,390 | cytochrome c oxidase subunit 4 isoform 2 | Racing performance | T/T T/C | ||
| 11353392 [ | 22 | 25,168,567 | agouti-signaling protein precursor | Black and bay color | Del 11 bp | ND | |
| 18641652 [ | 25 | 6,574,013-6,581,600 | syntaxin 17 | Gray coat color | Dup 4,600 | Neg |
Abbreviations: Del, Deletion; Ins, Insertion; Neg, Negative; ND, Not Determined; Dup, Duplication